Patents Assigned to ARBOR PHARMACEUTICALS, INC.
  • Sotalol compositions and uses of the same
    Patent number: 10206895
    Abstract: The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability. The present invention also relates to methods of using the oral solutions for treatment of diseases and disorders, such as delay in reoccurrence of atrial fibrillation/atrial flutter and/or ventricular arrhythmias.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: February 19, 2019
    Assignee: ARBOR PHARMACEUTICALS, INC.
    Inventors: H. Greg Thomas, Jeffrey S. Kiel
  • Sotalol compositions and uses of the same
    Patent number: 9724297
    Abstract: The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability. The present invention also relates to methods of using the oral solutions for treatment of diseases and disorders, such as delay in reoccurrence of atrial fibrillation/atrial flutter and/or ventricular arrhythmias.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: August 8, 2017
    Assignee: ARBOR PHARMACEUTICALS, INC.
    Inventors: H. Greg Thomas, Jeffrey S. Kiel
  • TREATMENT OF ACUTE OTITIS MEDIA WITH XYLITOL AND N-ACETYLCYSTEINE
    Publication number: 20090197956
    Abstract: The present invention relates to the discovery that the treatment of Acute Otis Media (AOM) can be accomplished by a synergistic combination of xylitol and N-acetylcysteine. The treatment with this combination shows that symptoms of AOM can be decreased and or treated to a greater degree than know with xylitol alone. The present invention includes both pharmaceutical compositions and methods of treatment.
    Type: Application
    Filed: February 4, 2008
    Publication date: August 6, 2009
    Applicant: ARBOR PHARMACEUTICALS, INC.
    Inventors: Jarrett T. Disbrow, Joshua R. Disbrow